Health : Page 19
October 5, 2023
Roche presented positive results from the primary analysis of the ongoing Rainbowfish study assessing the efficacy and safety of Evrysdi (risdiplam) in babies with pre symptomatic SMA (n=26), aged from birth to six weeks.
October 4, 2023
Israeli, Dutch, and Scottish researchers found how toxic proteins, which are involved in the development of Alzheimer\'s disease, accumulate in the brain, the Israel Institute of Technology (Technion) said in a statement.
October 4, 2023
Governor Ned Lamont and Comptroller Sean Scanlon announced that Connecticut residents can now enroll in a newly launched program enabling them to receive a discount card that can be presented at pharmacies to receive savings on certain medication.
October 4, 2023
New York City Mayor Eric Adams and NYC Health + Hospitals launched telehealth abortion access through Virtual ExpressCare becoming the first public health system in the nation to do so.
October 4, 2023
The Taiwan Centers for Disease Control announces the Moderna XBB vaccine will be available to the general public starting October 11th.
October 2, 2023
Hungarian born Katalin Kariko and Drew Weissman of the US have won the 2023 Nobel Prize in Physiology or Medicine for their research that led directly to the first mRNA vaccines to fight COVID-19, made by Pfizer and Moderna, according to the awarding body.
October 2, 2023
Research from the University of Cincinnati shows that exposure to PFAS may delay the onset of puberty in girls.
September 30, 2023
A dengue vaccine has been successfully tested for the first time in Bangladesh, raising hopes for the south Asian country to overcome the epidemic, scientists revealed in a new study, according to a statement.
September 29, 2023
Playing Tetris for fifteen minutes can prevent psychological trauma in mothers after a difficult birth.
September 29, 2023
On 21 September, the company that markets Blenrep asked for re-examination of the CHMP opinion.
September 28, 2023
Iran has managed to develop Alteplase (Altelyse), becoming the second producer after the U.S. of the medicine used to treat acute ischemic stroke.
September 27, 2023
GSK announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved Arexvy (respiratory syncytial virus vaccine, recombinant adjuvanted) for the prevention of RSV (respiratory syncytial virus) disease for adults 60 years of age and above.